American Regent Issues Nationwide Recall of Adequan® Canine and I.M. Lots
American Regent, Inc. is recalling two lots of Adequan® Canine and two lots of Adequan® I.M. due to safety concerns.
Asset
American
Indication
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The nationwide recall of Adequan® products raises significant safety concerns that could affect American Regent's reputation and market share in the veterinary sector. It is crucial for pharma strategy teams to assess the implications for sales and develop communication strategies to mitigate potential backlash from veterinarians and pet owners.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor for further details on the reasons for the recall and any potential regulatory actions from the FDA.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.